Universal Health Services financials
$175.73−0.99%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.64B | $4.50B | $4.49B | $4.50B | $4.28B | $4.10B | $4.11B | $3.96B | $3.91B | $3.84B | $3.70B | $3.56B |
| Gross profit | $4.64B | $3.21B | $4.49B | $4.50B | $4.28B | $2.99B | $4.11B | $3.96B | $3.91B | $3.84B | $3.70B | $3.56B |
| Gross margin | 100.0% | 71.4% | 100.0% | 100.0% | 100.0% | 73.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | $516.7M | $502.9M | $517.2M | $521.7M | $500.3M | $454.8M | $472.5M | $384.2M | $436.4M | $388.8M | $472.2M | $285.4M |
| Net income | $358.4M | $348.7M | $445.9M | $373.0M | $353.2M | $316.7M | $332.4M | $258.7M | $289.2M | $261.8M | $216.4M | $167.0M |
| Net margin | 7.7% | 7.8% | 9.9% | 8.3% | 8.2% | 7.7% | 8.1% | 6.5% | 7.4% | 6.8% | 5.8% | 4.7% |
| Diluted EPS | $5.98 | $5.65 | $7.06 | $5.86 | $5.43 | $4.80 | $4.96 | $3.80 | $4.26 | $3.82 | $3.16 | $2.40 |
| EBITDA | $684.0M | $658.3M | $680.6M | $676.7M | $652.3M | $603.2M | $619.3M | $533.7M | $583.9M | $529.8M | $472.2M | $422.6M |
| Operating cash flow | $443.3M | $401.6M | $574.7M | $380.7M | $549.0M | $360.0M | $658.4M | $333.0M | $679.3M | $396.4M | $452.4M | $161.7M |
| Free cash flow | $215.7M | $184.5M | $287.5M | $133.1M | $283.0M | $121.0M | $412.5M | $85.0M | $437.9M | $187.9M | $246.0M | -$38.3M |
| Diluted shares | 59.9M | 61.7M | 63.2M | 63.7M | 65.0M | 66.0M | 67.1M | 68.1M | 67.9M | 68.5M | 68.6M | 69.6M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $138.8M | $119.0M | $137.8M | $112.9M | $137.6M | $126.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $4.85B | $4.71B | $4.75B | $4.69B | $4.58B | $4.65B |
| Total assets | $15.94B | $15.68B | $15.53B | $15.34B | $14.99B | $14.88B |
| Total liabilities | $8.28B | $8.08B | $8.12B | $8.05B | $7.84B | $7.99B |
| Shareholders' equity | $7.58B | $7.53B | $7.34B | $7.23B | $7.09B | $6.87B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology